Informa's Fair Value Rises After Half-Year Results-But the 21% Analyst Upside Still Needs Harder Proof

Informa's revised fair value resets the debate

Informa's fair value has moved up, but the share price has not fully caught up. A 21.20% average analyst upside suggests the market still sees room for rerating, while a recent change in price target points to a more constructive view than the stock is reflecting. The question now is whether better expectations can hold up once investors demand harder proof of execution.

That proof started to look more credible in the half-year report. Informa posted half-year EPS of £0.27 versus £0.24 expected, alongside £2.06B of revenue versus £2.02B expected. More importantly, the core operating engine still looked stable, with 6.8% underlying H1 revenue growth and B2B live events up 8%. For a company that depends on live demand, that is a constructive sign.

The hesitation in the market is easy to understand. EPS fell 10.74% year over year, a reminder that a strong half does not erase earnings volatility. The stock's performance shows the same caution: it is up just 0.22% year to date versus the FTSE 100's 9.43%, and it has also lagged over one and three years.

What matters next is whether management's visibility turns into delivered results. The company highlighted 85% of 2026 revenue visibility and $800M of 2027 revenue already booked. If that visibility converts smoothly into cash flow without another margin setback, the valuation gap can close. If not, the analyst upside remains only theoretical.

Core trading improved while timing issues clouded the headline numbers

The durable parts of the business still look healthy

The main change is not that Informa became a different company. The half-year results did a better job of showing which parts of the business are still working and which parts are creating noise for investors who focus only on headline totals.

Informa reported strong underlying trading in B2B Live Events and Academic Markets, while TechTarget was steady rather than a source of major weakness in the half. That distinction matters because it keeps the core story intact even as the group numbers look messier.

The growth split makes that clear. Informa delivered 5.1% underlying revenue growth in the half, rising to 6.8% when non-recurring data contracts were excluded. Reported revenue growth was far lower, at 1.4%. That gap suggests the operating demand was healthier than the headline revenue figure alone implies.

Calendar shifts and Middle East timing are distorting the comparison

The biggest wrinkle is the event calendar. Informa said 15+ B2B Live Event brands were rescheduled from H1 to H2 within the Middle East. That helps explain why some revenue may have shifted out of the first half and can make the period look weaker than the underlying demand.

Still, the Middle East issue was not only a calendar effect. It also created commercial friction, with international exhibitors in the UAE and KSA under pressure and a corresponding hit to H1 margins. Bulls can argue demand is still there, especially with 2027 pacing slightly ahead of the same point last year. Bears will argue the region remains a real execution risk.

Margin pressure is the clearest quality watchpoint

The weaker profit picture is easier to spot than the revenue distortion. Informa's adjusted operating margin fell to 26.6% from 28.4%, a decline of about 2 percentage points. That appears tied in part to keeping the cost base in place in the Middle East despite the lower revenue, as well as softer performance in other areas.

TechTarget remains the most obvious drag. The unit was described as steady in the broader half-year read, but other evidence from the period pointed to weak growth and revenue shortfalls. Even so, that looks more like segment-specific weakness than proof that Informa's broader events model has weakened.

The more durable positive signal sits elsewhere. Academic Markets is still aiming for 5%+ growth by 2027, which matters if investors are judging whether Informa can compound steadily rather than simply rebound episodically.

What the market still needs to see in H2

The half-year results improved the operating case, but they did not settle it. The next few quarters need to show:

• The H2 rebound is more than a calendar catch-up. The rescheduled Middle East events need to translate into real delivered growth, not just reverse a timing issue.
• Margins recover as the cost base normalizes. If the 2 percentage point hit persists, investors may stop treating it as temporary noise.
• TechTarget stops weighing down the group. One underperforming unit can cap the multiple even if the rest of the portfolio is holding up.

Analyst upside remains meaningful, but it is still conditional

The half-year results likely lifted fair value, but they did not end the debate. With 6 analyst ratings pointing to an average target of GBX 1,095 against a current price of GBX 903, the market is still offering upside. The important caveat is that this is a wide range, not a consensus promise: targets stretch from GBX 850 to GBX 1,285, and one of six analysts remains on Hold.

Why bulls still have room to argue

The bullish case works if investors view Informa as a mature cash generator rather than a high-flying growth story. The business is still showing 6.8% underlying H1 revenue growth, and the company appears to have meaningful visibility into the remainder of 2026. At 14.42x forward earnings, the valuation is not extreme for a business with that mix of stability and visibility.

JPMorgan's £12.85 Buy target represents the more optimistic end of the range. It is the sort of target that becomes more believable if the market decides earnings quality is stronger than the headline half suggests.

Why the market may still hesitate

The bearish case is simpler: not every pound of forward demand deserves the same multiple. Citi's £8.50 Hold target sits 4.08% below current levels, which underscores that investors are not united on the rerating. When a business has already shown earnings volatility and a noticeable margin hit, a softer view can matter as much as the bullish targets.

For now, the stock still looks like a proof story. Fair value may have moved higher, but the market appears willing to reward the upper end of the range only if the second half delivers cleaner execution.